Inhibition of transglutaminase-mediated microbial infection of a mammalian host
CA 2347983 A1 · Owner: Sundstrom, Paula · Inventors: Sundstrom, Paula; Bradway, Steven
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The infection of a mammalian host by a microorganism Candida albicans can be prevented or treated through the administration the substrate for transglutaminases Hwp or antibodies against this substrates that inhibit the transglutaminase-mediated interaction of the microorganism with the mammalian host. These compounds may be used in the identification prevention or , treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans, for example those having AIDS or undergoing , transplantation or anti-cancer therapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 26, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 26, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 26, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.